Skip to main content
Caplight Logo









Llamando al Doctor

Llamando al Doctor

Private
Buenos AiresHealthcare & Life Scienceshttps://llamandoaldoctor.com/

Last Round

Strategic

Nov 13, 2018

Total Funding Raised

$350,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Llamando al Doctor is a healthtech company that provides a 24/7 telemedicine platform connecting patients with medical professionals via video consultations.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Vertical SaaS

Business Model

B2B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Non-AI

Keywords

telemedicinetelehealthremote medical consultationdigital healthemployee health benefitsvirtual doctorB2B2Ccorporate wellnesson-demand healthcarewhite-label telemedicinehealth techsubscription healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Llamando al Doctor Comparables

Compare Llamando al Doctor with similar companies based on industry and business-model similarity.

Llamando al Doctor comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DOC24
89%
Mediclic
86%
1DOC3
83%

Llamando al Doctor Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicNov 13, 2018
SeedSep 1, 2016

Key People

Founding team and executive leadership

Guillermo Gonzalez

Chief Executive Officer, Director comercial

Executive Team

Martín Lucas Golini

Chief Technology Officer

Executive Team

Ricardo Gordillo

Chief Operating Officer

Executive Team

Llamando al Doctor Investors

Notable investors and investment history

Llamando al Doctor investors
InvestorRounds
CITESSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors grew 42% MoM, reaching 61.5K.

  • Apr 6, 2026

    Monthly visitors increased 58% MoM.

Llamando al Doctor Filings

Explore SEC and related filing metadata, where available.

Llamando al Doctor filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Llamando al Doctor's valuation, stock price, and market status.

Is Llamando al Doctor a public or private company?

Llamando al Doctor is a private company.

What is the current stock price of Llamando al Doctor?

Llamando al Doctor is a private company with no public stock price. No recent secondary market data is available.

How much is Llamando al Doctor worth (valuation)?

Valuation information for Llamando al Doctor is not publicly available.

Can I buy Llamando al Doctor stock?

Llamando al Doctor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Llamando al Doctor's last funding round?

Llamando al Doctor's most recent funding round was Strategic on November 13, 2018.

Who are the main investors in Llamando al Doctor?

Key investors in Llamando al Doctor include CITES.

Will Llamando al Doctor IPO soon?

No public IPO plans have been announced for Llamando al Doctor.

How can I track Llamando al Doctor secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Llamando al Doctor's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBuenos Aires
Employee Range91
Year FoundedN/A
Last FundingNov 13, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?